Does PANTOPRAZOLE Cause Mobility decreased? 1,081 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,081 reports of Mobility decreased have been filed in association with PANTOPRAZOLE (Pantoprazole Sodium). This represents 1.4% of all adverse event reports for PANTOPRAZOLE.
1,081
Reports of Mobility decreased with PANTOPRAZOLE
1.4%
of all PANTOPRAZOLE reports
707
Deaths
783
Hospitalizations
How Dangerous Is Mobility decreased From PANTOPRAZOLE?
Of the 1,081 reports, 707 (65.4%) resulted in death, 783 (72.4%) required hospitalization, and 737 (68.2%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PANTOPRAZOLE. However, 1,081 reports have been filed with the FAERS database.
What Other Side Effects Does PANTOPRAZOLE Cause?
Chronic kidney disease (28,127)
Acute kidney injury (15,961)
Renal failure (11,543)
End stage renal disease (8,523)
Renal injury (7,070)
Drug ineffective (5,487)
Off label use (4,279)
Pain (4,057)
Dyspnoea (4,052)
Fatigue (3,797)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which PANTOPRAZOLE Alternatives Have Lower Mobility decreased Risk?
PANTOPRAZOLE vs PANTOPRAZOLE ANHYDROUS
PANTOPRAZOLE vs PANTOTHENIC ACID
PANTOPRAZOLE vs PAPAVERINE
PANTOPRAZOLE vs PARACETAMOL
PANTOPRAZOLE vs PARATHYROID HORMONE